Literature DB >> 10470261

Analysis of the latency-associated transcript/UL1-3.5 gene cluster promoter complex of pseudorabies virus.

A K Cheung1, T A Smith.   

Abstract

During latency, pseudorabies virus (PRV) DNA is preferentially retained in the neurons of the trigeminal ganglion and a spliced 8.5-kilobase poly-A RNA, designated large latency transcript (LLT), is synthesized. Because LLT is the only transcript made during the latent phase, the LLT promoter may be unique among all other PRV promoters that are active in productive infections. Organization of the PRV LLT promoter is quite complex because it coincides with the UL1-3.5 gene cluster promoter, but in the opposite orientation. By conventional designation, LLT is transcribed in the rightward direction while the UL1-3.5 gene cluster is transcribed in the leftward orientation. In this work, activities of the LLT promoter and the UL1-3.5 gene cluster promoter were investigated by transient reporter gene expression assay in cells of neuronal and non-neuronal origins. There are two TATA boxes in this region. We examined the promoter activities of the first TATA box with its 5' sequence (LAP1) and the second TATA box with its 5' sequence (LAP2). The UL1-3.5 promoter driven constructs gave no reporter gene activity in any of the experiments. Reporter gene activity was detected with LAP2 gene constructs, but not with LAP1 constructs, in both neuronal and non-neuronal cells. This is surprising because transcription of PRV LLT in vivo has been attributed to LAP1 and the initiation site was mapped downstream of the LAP1 TATA box and upstream of the LAP2 TATA box. Although LAP1 was not active in these experiments, there was a 3- to 10-fold enhancement of activity when LAP1 and LAP2 were placed in tandem.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470261     DOI: 10.1007/s007050050511

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region.

Authors:  Jennifer L Taylor; Heather N Bennett; Beth A Snyder; Patrick S Moore; Yuan Chang
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

3.  Expression of the pseudorabies virus latency-associated transcript gene during productive infection of cultured cells.

Authors:  L Jin; G Scherba
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Identification of the pseudorabies virus promoter required for latency-associated transcript gene expression in the natural host.

Authors:  L Jin; W M Schnitzlein; G Scherba
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Suppression of promoter activity of the LAT gene by IE180 of pseudorabies virus.

Authors:  Chia-Jen Ou; Min-Liang Wong; Chienjin Huang; Tien-Jye Chang
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

6.  Characterization of the Dynamic Transcriptome of a Herpesvirus with Long-read Single Molecule Real-Time Sequencing.

Authors:  Dóra Tombácz; Zsolt Balázs; Zsolt Csabai; Norbert Moldován; Attila Szűcs; Donald Sharon; Michael Snyder; Zsolt Boldogkői
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

7.  Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS.

Authors:  Carola J Maturana; Jessica L Verpeut; Thomas J Pisano; Zahra M Dhanerawala; Andrew Esteves; Lynn W Enquist; Esteban A Engel
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-14       Impact factor: 6.698

Review 8.  The Role of Latency-Associated Transcripts in the Latent Infection of Pseudorabies Virus.

Authors:  Jiahuan Deng; Zhuoyun Wu; Jiaqi Liu; Qiuyun Ji; Chunmei Ju
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.